A biologist by training, Pierre Calleja began his career at the Ifremer research institute where his work centered on the development of larval breeding techniques in marine farms.
He then went on to create Kurios (a subsidiary of Sanofi Aquaculture) in 1992 where he developed an innovative range of larval feed and fish feed nutritional supplements designed to optimize breeding techniques. By 1999, Kurios’s revenues has doubled year-on-year to stand at €4 million, with exports accounting for 80% of the company’s sales. In 2000, Pierre Calleja sold Kurios to the global leader in larval fish nutrition, INVE.
From 2000 to 2005, Pierre Calleja worked in collaboration with Ifremer research institute on an R&D project for the mass production of microalgae under heterotrophic conditions.
In 2005, he acquired Aquatyca (specialized in aquariology fish feed) which he went on to sell in 2008.
In 2007, Pierre Calleja filed two patents linked to the farming of microalgae which led to the creation of Fermentalg in 2009. More information...
 |
| Pierre Calleja |
No comments:
Post a Comment